Generic · Injection
Succinylcholine 20 mg/mL injection price what pharmacies pay, and what you should
There is no weekly pharmacy acquisition cost for succinylcholine 20 mg/ml injection this week. The makers, package codes, recalls and label are below.
What people paid for succinylcholine 20 mg/ml injection
What did your pharmacy charge? It takes 30 seconds, it's anonymous - and it shows everyone which pharmacies are fair.
Supply status: shortages & recalls
Shortages
- Succinylcholine Chloride, Injection, 20 mg/1 mL (NDC 63323-943-10)Discontinuation of the manufacture of the drug
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
Showing the 6 most relevant of 45 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
Every manufacturer and package code
21 companies sell succinylcholine 20 mg/ml injection under 33 package codes (NDCs).
All 33 package codes
A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.
Other succinylcholine strengths and forms
| Strength and form | Per unit | Pharmacies pay | ||
|---|---|---|---|---|
| 20 mg/mL, 10 mL prefilled syringe | Not priced this week | |||
| 20 mg/mL, 5 mL prefilled syringe | Not priced this week | |||
Official label & what changed
These highlights do not include all the information needed to use SUCCINYLCHOLINE CHLORIDE INJECTION safely and effectively. See full prescribing information for SUCCINYLCHOLINE CHLORIDE INJECTION.SUCCINYLCHOLINE CHLORIDE injection, for intravenous or intramuscular use Initial U.S. Approval: 1952
WARNING: VENTRICULAR DYSRHYTHMIAS, CARDIAC ARREST, AND DEATH FROM HYPERKALEMIC RHABDOMYOLYSIS IN PEDIATRIC PATIENTS
Acute rhabdomyolysis with hyperkalemia followed by ventricular dysrhythmias, cardiac arrest, and death has occurred after the administration of succinylcholine to apparently healthy pediatric patients who were subsequently found to have undiagnosed skeletal muscle myopathy, most frequently Duchenne muscular dystrophy [see Warnings and Precautions (5.1)].
When a healthy appearing pediatric patient develops cardiac arrest within minutes after administration of Succinylcholine Chloride Injection, not felt to be due to inadequate ventilation, oxygenation or anesthetic overdose, immediate treatment for hyperkalemia should be instituted. In the presence of signs of malignant hyperthermia, appropriate treatment should be instituted concurrently [see Warnings and Precautions (5.1)].
Reserve the use of Succinylcholine Chloride Injection in pediatric patients for emergency intubation or instances where immediate securing of the airway is necessary, e.g., laryngospasm, difficult airway, full stomach, or for intramuscular use when a suitable vein is inaccessible [see Warnings and Precautions (5.1)].
WARNING: VENTRICULAR DYSRHYTHMIAS, CARDIAC ARREST, AND DEATH FROM HYPERKALEMIC RHABDOMYOLYSIS IN PEDIATRIC PATIENTS
See full prescribing information for complete boxed warning.
Acute rhabdomyolysis with hyperkalemia followed by ventricular dysrhythmias, cardiac arrest, and death has occurred after use in apparently healthy pediatric patients who were subsequently found to have undiagnosed skeletal muscle myopathy. (5.1)
When a healthy-appearing pediatric patient develops cardiac arrest soon after administration of Succinylcholine Chloride Injection, not felt to be due to other causes, immediate treatment for hyperkalemia should be instituted. In the presence of signs of malignant hyperthermia, appropriate treatment should be instituted concurrently. (5.1)
Reserve use of Succinylcholine Chloride Injection in pediatric patients for emergency intubation or instances where immediate securing of the airway is necessary, or for intramuscular use when a suitable vein is inaccessible. (5.1)
Recent major changes (as listed on the label)
Contraindications (4)
| 11/2022 |
Warnings and Precautions, Malignant Hyperthermia (5.5)
| 11/2022 |
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Questions about succinylcholine 20 mg/ml injection
Who makes succinylcholine 20 mg/ml injection?
21 companies: BE Pharmaceuticals Inc., Camber Pharmaceuticals, Inc., Devatis, Inc., Dr.Reddy's Laboratories Inc.,, Eugia US LLC, Fresenius Kabi USA, LLC, Gland Pharma Limited, HF Acquisition Co LLC, DBA HealthFirst, Hikma Pharmaceuticals USA Inc., Indoco Remedies Limited, Lifestar Pharma LLC, Medical Purchasing Solutions, LLC and more. See every package code.
Is succinylcholine in shortage?
Yes - 1 product is listed as short or being discontinued. Details.
Has succinylcholine been recalled?
45 recalls on record, 4 ongoing. Recalls name specific lots - check yours.
What does "pharmacies pay" mean?
It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.
Talk about succinylcholine 20 mg/ml injection
No comments yet. Questions, tips, what worked for you - start the conversation.